Utama › Penyakit Paru Interstisial › Texas › Dallas
Kajian klinikal Penyakit Paru Interstisial di Dallas, TX
9 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi dalam dan sekitar Dallas (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Mengambil pesertaFasa 3
- Baylor University Medical Center, Dallas
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaFasa 2
- Baylor University Medical Center, Dallas
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Mengambil peserta
- Baylor University Medical Center, Dallas
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaKajian pemerhatian
- Baylor University Medical Center, Dallas
- UT Southwest Medical Center Heart and Lung Clinic, Dallas
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Mengambil pesertaKajian pemerhatian
- University of Texas Southwestern, Dallas
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Mengambil pesertaKajian pemerhatian
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Mengambil pesertaFasa 3
- Baylor University Medical Center, Dallas
- UT Southwestern Medical Center-Advanced Lung Clinic, Dallas
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Mengambil pesertaFasa 2
- University of Texas Southwestern Medical Center, Dallas
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Mengambil pesertaFasa 2
- aTyr Investigative Site, Dallas
Kajian Penyakit Paru Interstisial di bandar lain
- New York City, NY18 kajian
- Philadelphia, PA16 kajian
- Los Angeles, CA14 kajian
- Kansas City, KS13 kajian
- Durham, NC13 kajian
- Charleston, SC13 kajian
- Chicago, IL12 kajian
- Houston, TX12 kajian
- Ann Arbor, MI11 kajian
- Aurora, CO11 kajian
- Phoenix, AZ9 kajian
- Salt Lake City, UT9 kajian
Kajian lain di Dallas
- Kanser Payudara55 kajian
- Kanser Paru-paru Bukan Sel Kecil52 kajian
- Kanser Metastatik42 kajian
- Kegagalan Jantung42 kajian
- Kanser (semua jenis)37 kajian
- Kanser Prostat36 kajian
- Kanser Kolorektal33 kajian
- Obesiti30 kajian
- Kanser Ovari28 kajian
- Kanser Pundi Kencing27 kajian
- Kanser Paru-paru27 kajian
- Kanser Endometrium24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.